Perioperative Chemotherapy with FLOT Improves Survival Among Patients with Resectable Oesophageal Adenocarcinoma By Ogkologos - February 10, 2025 43 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the ESOPEC study Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Extension of Therapeutic Indications for Nivolumab and Ipilimumab to Unresectable or Advanced HCC ESMO Sarcoma and Rare Cancers Congress 2025, Lugano, Switzerland, 20-22 March New on NCI’s Websites for March 2025 MOST POPULAR Tisagenlecleucel Is Safe and Effective in Pretreated Patients with Relapsed/Refractory Follicular... December 21, 2021 New on NCI’s Websites for January 2020 January 2, 2020 Identifying Safer Ways to Look for Recurrence After Testicular Cancer Surgery April 19, 2022 Why people and culture matter in research August 10, 2021 Load more HOT NEWS EMA Starts Review of Rucaparib EMA Recommends Extension of Therapeutic Indications for Nivolumab and Ipilimumab Neighborhood Celebrates Teen’s Last Chemo Session With Socially-Distanced Parade Remote Monitoring of Patients Treated with Oral Anticancer Drugs Improves Patient...
